Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

This study has been withdrawn prior to enrollment.

(Sponsor withdrew support for study due to reorganization and project prioritization)

Sponsor:

Information provided by (Responsible Party):

Teva GTC

ClinicalTrials.gov Identifier:

NCT01433432

First received: September 12, 2011

Last updated: March 5, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	August 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)